Acquiring Company
Lisata Therapeutics
Acquired Company
Marea Therapeutics
Description
On September 17, 2026, Lisata Therapeutics, Inc. acquired Marea Therapeutics, Inc. as part of a strategic merger. This transaction involved the merger of First Merger Sub with and into Marea, resulting in Marea becoming a wholly owned subsidiary of Lisata. This acquisition is expected to enhance Lisata's therapeutic development capabilities.
Quick answer
Lisata Therapeutics is acquiring Marea Therapeutics, announced September 17, 2026. Lisata Therapeutics is based in Basking Ridge, New Jersey, United States.
- How much did Lisata Therapeutics pay for Marea Therapeutics?
- The deal value was not disclosed.
- What does Lisata Therapeutics do?
- Lisata Therapeutics Inc (NASDAQ:LSTA) is a pharmaceutical company that is partnering with the University of Cincinnati to investigate endometriosis therapy.
- Where are Lisata Therapeutics and Marea Therapeutics based?
- Lisata Therapeutics is based in Basking Ridge, New Jersey, United States. Marea Therapeutics is based in South San Francisco, California, United States.
- Who are the decision-makers at Lisata Therapeutics?
- Fundz holds 2 contacts at Lisata Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Aurinia completes acquisition of Kezar Life Sciences (August 29, 2026)
- Jazz Pharmaceuticals acquires Actio Biosciences (August 10, 2026)
- Supernus to merge with Indivior Pharmaceuticals (August 3, 2026)
- Pelthos to merge with Castle Creek Biosciences (October 30, 2026)
- Ambrose Healthcare acquires AM-Pharma for rare disease (October 20, 2026)
Who to call at Lisata Therapeutics, and when
When Lisata Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lisata Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lisata Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lisata Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lisata Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Marea Therapeutics?
Marea Therapeutics was acquired by Lisata Therapeutics, based in Basking Ridge. The deal was reported on September 17, 2026. Lisata Therapeutics Inc (NASDAQ:LSTA) is a pharmaceutical company that is partnering with the University of Cincinnati to investigate endometriosis therapy. Lisata Therapeutics is publicly traded (LSTA) and operates in Biotechnology.
When did Lisata Therapeutics acquire Marea Therapeutics?
Lisata Therapeutics's acquisition of Marea Therapeutics was reported on September 17, 2026. On September 17, 2026, Lisata Therapeutics, Inc. acquired Marea Therapeutics, Inc. as part of a strategic merger. This transaction involved the merger of First Merger Sub with and into Marea, resulting in Marea becoming a wholly owned subsidiary of Lisata. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Marea Therapeutics do?
Marea Therapeutics is a clinical-stage biotechnology company focused on developing a new generation of medicines for cardiometabolic diseases. It is privately held, operating in Biotechnology, and is based in South San Francisco.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.